2025-04-14 22:08:27
Latest Post
Shantai Industries Limited fixes May 9, 2025 as record date for stock split
HCLTech integrates NVIDIA AI Enterprise and Omniverse with HCLTech's GenAI solutions
Sasken Technologies completes acquisition of Borqs Technologies to Strengthen IoT and 5G Product Engineering Capabilities
Tata Power Renewable Energy Ltd reaches 10.9 GW capacity after signing PPA with NTPC Ltd for 200 MW Firm and Dispatchable Renewable Energy Project
Cyient secures Strategic Engagement with GreenH and Luxcara for Hydrogen Project in Bodø, Norway
Stock Report
Morepen Laboratories Ltd consolidated Q2 FY2023-24 net profit increases to Rs. 21.25 crores
Posted On : 2023-11-02 23:26:45( TIMEZONE : IST )
Morepen Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2023.
Financial Results (Q2 FY2024) - QoQ Comparison
The company has reported total income of Rs. 425.0058 crores during the period ended September 30, 2023 as compared to Rs. 403.4561 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs. 21.2558 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 14.6329 crores for the period ended June 30, 2023.
The company has reported EPS of Rs. 0.42 for the period ended September 30, 2023 as compared to Rs. 0.29 for the period ended June 30, 2023.
| Financials | Q2 FY2024 | Q1 FY2024 | % Change |
| Total Income | ₹ 425.0058 crs | ₹403.4561 crs |  5.34% |
| Net Profit | ₹21.2558 crs | ₹14.6329 crs | 45.26% |
| EPS | ₹0.42 | ₹0.29 | 44.83% |
Financial Results (Q2 FY2024) - YoY Comparison
The company has reported total income of Rs. 425.0058 crores during the period ended September 30, 2023 as compared to Rs.403.8524 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.21.2558 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.15.8109 crores for the period ended September 30, 2022.
The company has reported EPS of Rs.0.42 for the period ended September 30, 2023 as compared to Rs.0.33 for the period ended September 30, 2022.
| Financials | Q2 FY2024 | Q2 FY2023 | % Change |
| Total Income | ₹ 425.0058 crs | ₹403.8524 crs | 5.24% |
| Net Profit | ₹21.2558 crs | ₹15.8109 crs | 34.44% |
| EPS | ₹0.42 | ₹0.33 | 27.27% |
Financial Results (Half Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.828.4619 crores during the 6 Months period ended September 30, 2023 as compared to Rs.707.1673 crores during the 6 Months period ended September 30, 2022.
The company has posted net profit / (loss) of Rs.35.8887 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.21.4408 crores for the 6 Months period ended September 30, 2022.
The company has reported EPS of Rs.0.71 for the 6 Months period ended September 30, 2023 as compared to Rs.0.43 for the 6 Months period ended September 30, 2022.
| Financials | Half Year Ended FY2024 | Half Year Ended FY2023 | % Change |
| Total Income | ₹828.4619 crs | ₹707.1673 crs | 17.15% |
| Net Profit | ₹35.8887 crs | ₹21.4408 crs | 67.39% |
| EPS | ₹0.71 | ₹0.43 | 65.12% |
Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 35.44 as compared to the previous close of Rs. 33.64. The total number of shares traded during the day was 400025 in over 1918 trades.
The stock hit an intraday high of Rs. 37.14 and intraday low of 33.75. The net turnover during the day was Rs. 14125201.00.
